SCHEMBL1366495

SCHEMBL1366495

O=C(C=Cc1ccc(Cl)cc1)c1cc2cc(Br)ccc2oc1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.57
STAT3 P40763 1/20 0.57
GPR35 Q9HC97 2/20 0.56
GRIN1 Q05586 1/20 0.56
GRIN2A Q12879 1/20 0.56
GRIN2B Q13224 1/20 0.56
GRIN2C Q14957 1/20 0.56
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 3/20 0.54
HPGD P15428 2/20 0.54
MEN1 O00255 1/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 1/20 0.54
ALOX12 P18054 1/20 0.54
RECQL P46063 1/20 0.54
KMT2A Q03164 1/20 0.54
MCL1 Q07820 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
MAOB P27338 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1367343 1.00 MAOA (0.57) MAOASTAT3GPR35GRIN1GRIN2A
SCHEMBL1366493 1.00 MAOA (0.57) MAOASTAT3GPR35GRIN1GRIN2A
SCHEMBL4382617 0.93 GRIN1 (0.62) MAOASTAT3GPR35GRIN1GRIN2A
SCHEMBL4382614 0.93 GRIN1 (0.62) MAOASTAT3GPR35GRIN1GRIN2A
SCHEMBL1369407 0.90 MAOB (0.62) MAOAGPR35ALDH1A1KDM4EMEN1
SCHEMBL1367322 0.90 MAOB (0.62) MAOAGPR35ALDH1A1KDM4EMEN1
SCHEMBL1367321 0.90 MAOB (0.62) MAOAGPR35ALDH1A1KDM4EMEN1
SCHEMBL1368435 0.85 ALDH1A1 (0.59) MAOASTAT3GPR35GRIN1GRIN2A
SCHEMBL1365997 0.85 ALDH1A1 (0.59) MAOASTAT3GPR35GRIN1GRIN2A
SCHEMBL1368322 0.85 MAOA (0.76) MAOAGPR35GRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11958835-B1 6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(4-chlorophenyl)-2-alkoxynicotinonitrile as antimicrobial agents King Faisal University (SA) 2024-04-16 US claimed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US claimed
WO-2006132947-A2 3-ACYL COUMARINS, THIOCHROMONES AND QUINOLONES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-12-14 WO claimed
US-11958835-B1 6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(4-chlorophenyl)-2-alkoxynicotinonitrile as antimicrobial agents King Faisal University (SA) 2024-04-16 US disclosed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed
WO-2006132947-A2 3-ACYL COUMARINS, THIOCHROMONES AND QUINOLONES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11958835-B1 6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(4-chlorophenyl)-2-alkoxynicotinonitrile as antimicrobial agents PNN, NCL, BECN1 MAOA 1640/4885STAT3 3362/4885GPR35 4863/4885
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS MAOA 3570/4885STAT3 3059/4885GPR35 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.